Schedule of data collection
Items | Screening period within 1 week | Treatment period 1–6 months | Follow-up period 7–12 months |
Signed informed consent | √ | ||
Inclusion/exclusion criteria | √ | ||
Demographic data | √ | ||
Medical history, course of disease, treatment history | √ | ||
Combined diseases | √ | ||
Concomitant medications | √ | √ | |
Plaque characteristics | √ | √ | |
Blood lipid indicators | √ | √ | |
Efficacy of angina symptoms | √ | √ | |
SAQ | √ | √ | |
MACEs | √ | ||
hs-CRP | √ | √ | |
Vital signs | √ | √ | |
Blood, urine and stool routine | √ | √ | |
Liver and kidney function | √ | √ | |
Adverse events | √ | √ | |
eCRF examination | √ |
Vital signs: temperature, heart rates, breathing and blood pressure.
√represents the indicators tested in the specific time period.
CRP, C-reactive protein; eCRF, electronic case report form; MACE, major adverse cardiac event; SAQ, Seattle Angina Questionnaire.